Swiss Postpartum Hypertension Cohort

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk.

Current disease management strategies will be evaluated.

Eligibility criteria

Qualifiers

all women with hypertensive disorders of pregnancy

postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery)

women with preexisting hypertension or

women on antihypertensive medication

Disqualifiers

delivery > 14 days

lack of consent to participate in the study, language barriers or lack of general understanding

Trial design

Treatments tested in this trial

  • Data collection for parameters of organ damage (cardiac and renal blood markers)
  • Data collection for blood pressure (BP)
  • Home-based blood pressure management (substudy)
  • Biomarker Profiles (substudy)
  • Data collection on patient reported outcomes

Treatment groups

No treatment groups listed